Mirum Pharmaceuticals, Inc. (MIRM)
92.47
-0.71
(-0.76%)
USD |
NASDAQ |
Nov 10, 09:36
Mirum Pharmaceuticals Cash and Short Term Investments (Quarterly) : 373.69M for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 373.69M |
| June 30, 2026 | 438.29M |
| March 31, 2026 | 386.26M |
| December 31, 2025 | 383.33M |
| September 30, 2025 | 375.55M |
| June 30, 2025 | 304.55M |
| March 31, 2025 | 277.67M |
| December 31, 2024 | 280.32M |
| September 30, 2024 | 284.44M |
| June 30, 2024 | 278.37M |
| March 31, 2024 | 302.84M |
| December 31, 2023 | 286.33M |
| September 30, 2023 | 306.03M |
| June 30, 2023 | 329.95M |
| March 31, 2023 | 132.07M |
| December 31, 2022 | 151.72M |
| Date | Value |
|---|---|
| September 30, 2022 | 185.35M |
| June 30, 2022 | 124.95M |
| March 31, 2022 | 139.91M |
| December 31, 2021 | 156.54M |
| September 30, 2021 | 190.03M |
| June 30, 2021 | 223.85M |
| March 31, 2021 | 213.11M |
| December 31, 2020 | 231.82M |
| September 30, 2020 | 133.75M |
| June 30, 2020 | 149.34M |
| March 31, 2020 | 159.53M |
| December 31, 2019 | 116.66M |
| September 30, 2019 | 126.26M |
| June 30, 2019 | 84.19M |
| March 31, 2019 | 49.49M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Incyte Corp. | 3.855B |
| Galectin Therapeutics, Inc. | 13.27M |
| TG Therapeutics, Inc. | 556.71M |
| Ardelyx, Inc. | 285.34M |
| Kodiak Sciences, Inc. | 125.90M |